Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, “Our study suggests that besides obesity and diabetes, GLP-1-agonists may also help in the treatment of alcohol and substance use disorders; however, these findings need to be further validated in randomized controlled trials.”

The researchers also noted that the two GLP-1 drugs appeared to outperform standard anti-alcoholism medications, such as naltrexone, disulfiram and acamprostate, in lowering hospitalizations among people with alcohol use disorder, although better studies ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Ozempic, a diabetes drug that has become a popular drug for weight loss, has another use that could help tens of millions of Americans, researchers say. In a study published in the journal JAMA Psychiatry,